One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Diabetes care and AI: a looming threat or a necessary advancement?
doi : 10.1016/S2213-8587(23)00174-2
Volume 11, Issue 7, July 2023, Page 441
Oxytocin deficiency in patients with arginine vasopressin deficiency (central diabetes insipidus)
Mirela Diana Ilie a b, Gérald Raverot b c
Importance of residual insulin secretion in type 1 diabetes
Jay S Skyler a
Cardiometabolic risk factor prevalence in a representative population of adults in India
Sarah Wild a
From paediatric to adult diabetes care: lost in transition
Carine de Beaufort a, Apoorva Gomber b, Suzanne Sap c, Lori Laffel d e f
Sugar, sugary drinks, and health: has the evidence achieved the sweet spot for policy action?
Dariush Mozaffarian a
Vin Tangpricha: advocating evidence-based transgender care
doi : 10.1016/S2213-8587(23)00160-2
Volume 11, Issue 7, July 2023, Page 452
Improving health equity through data collection
doi : 10.1016/S2213-8587(23)00148-1
Volume 11, Issue 7, July 2023, Page 453
Correction to Lancet Diabetes Endocrinol 2023; 11: 414–25
doi : 10.1016/S2213-8587(23)00158-4
Volume 11, Issue 7, July 2023, Page e9
Correction to Lancet Diabetes Endocrinol 2023; 11: 75–76
doi : 10.1016/S2213-8587(23)00147-X
Volume 11, Issue 7, July 2023, Page e9
Correction to Lancet Diabetes Endocrinol 2022; 10: 720–31
doi : 10.1016/S2213-8587(23)00146-8
Volume 11, Issue 7, July 2023, Page e9
Oxytocin in response to MDMA provocation test in patients with arginine vasopressin deficiency (central diabetes insipidus): a single-centre, case-control study with nested, randomised, double-blind, placebo-controlled crossover trial
Cihan Atila MD a e, Friederike Holze PhD b e, Rakithan Murugesu BSc a e, Nikki Rommers PhD e, Nina Hutter BSc a e, Nimmy Varghese MSc c d, Clara O Sailer MD PhD a e, Prof Anne Eckert PhD c d, Prof Markus Heinrichs PhD f, Prof Matthias E Liechti MD b e, Prof Mirjam Christ-Crain MD PhD a e
Residual insulin secretion in individuals with type 1 diabetes in Finland: longitudinal and cross-sectional analyses
Minna Harsunen MD a b e †, Jani Haukka MSc a b f †, Valma Harjutsalo PhD a b f, Nina Mars PhD c h, Anna Syreeni PhD a b f, Taina Härkönen PhD b, Annemari Käräjämäki MD c i, Jorma Ilonen DMSci j, Mikael Knip DMSc b k, Niina Sandholm DSc a b f, Päivi Johanna Miettinen DMSc d e, Prof Per-Henrik Groop DMSc a b f l, Tiinamaija Tuomi DMSc a b c g m
Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)
doi : 10.1016/S2213-8587(23)00119-5
Volume 11, Issue 7, July 2023, Pages 474-489
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets
Katrien Benhalima PhD MD a, Kaat Beunen MBiomed a, Sarah E Siegelaar PhD MD b c, Prof Rebecca Painter PhD MD d e, Prof Helen R Murphy MD f, Prof Denice S Feig MD MSc g, Prof Lois E Donovan MD h, Sarit Polsky MD MPH i, Elizabeth Buschur PhD MD j, Prof Carol J Levy MD k, Prof Yogish C Kudva MD l, Prof Tadej Battelino PhD MD m n, Lene Ringholm PhD MD o, Prof Elisabeth R Mathiesen PhD MD o, Prof Chantal Mathieu PhD MD a
Disparities in diabetes prevalence and management by race and ethnicity in the USA: defining a path forward
doi : 10.1016/S2213-8587(23)00129-8
Volume 11, Issue 7, July 2023, Pages 509-524
